Drawing for SENOLYTIC COMPLEX

USPTO serial 99554525

SENOLYTIC COMPLEX

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
KLUWE, CHERYL D
Law office
TMO LAW OFFICE 126

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SENOLYTIC COMPLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dean G. Stathakis

Dean G. Stathakis UltimatEdge IP Law Group. P.C.9234 Kingston Pike #319Knoxville, TN 37922-2380United States

Goods and services

ClassDescriptionStatusFirst use
003Anti-aging cream; Anti-aging moisturizer; Cosmetic ingredient complex composed of antioxidants, senolytic, senomorphic, or senostatic agents, humectant, occlusives or hydrating agents, and anti-inflammatory agents sold as an integral component of non-medicated skincare preparations; Cosmetic ingredient complex composed of antioxidants, anti-aging agents, moisturizers, and anti-inflammatory agents sold as an integral component of non-medicated skincare preparations; Cosmetic preparations for hydrating the skin; Cosmetic preparations for protecting the skin from the sun's rays; Cosmetic preparations for skin care; Cosmetic preparations for skin renewal; Non-medicated skin care preparations; Non-medicated body care preparations, namely, anti-aging serum and anti-aging complex; Skin conditioning creams for cosmetic purposes; Skin hydrating preparations for cosmetic purposes; Wrinkle-minimizing cosmetic preparations for topical facial use; Wrinkle removing skin care preparations; Non-medicated anti-aging serum; all of the foregoing containing senolytic or senomorphic ingredients.ACTIVEAug 21, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 3, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 3, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 3, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 4, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Aug 4, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
May 4, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2026DOCKASSIGNED TO EXAMINER—
Apr 9, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 18, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 18, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance